Daeyang Medical Develops a Beauty Treatment Device Decell

News provided by

Nov. 08, 2013 10:46

공유
스크랩
인쇄
글자크기
Font Size
- ASmall
- AMedium
- ALarge
- AVery Large

WONJU--(Korea Newswire)--Medical device Decell developed by Daeyang Medical Co., Ltd.(CEO Yun Il Yong, www.daeyangmed.com) uses the shock wave to remove fat and cellulite in order to help building fit body and reduce pain. Also, shock wave can be used to strengthen muscular tissue, remove lymphostasis, and give a medical massage. Daeyang Medical said Decell's benefit is that it can be used for various treatments and its effect is shown quickly as patients invest time and money.

Daeyang Medical adopted the extracorporeal shock wave therapy (ESWT) to develop the beauty treatment device Decell. ESWT is a therapy used for chronic treatment of skeletal muscle. Shock wave is short and strong and is faster than the speed of sound. ESWT was used to treat kidney stone but is now widely used to relieve pain. Among different ESWTs, Decell selected and applied the acoustic wave therapy.

The acoustic wave therapy improves lymphatic circulation and metabolism and it also accelerates lipolysis. Its cellulite treatment effect varies. It promotes skin reproduction and gives the skin long-lasting elasticity. It is receiving excellent feedbacks from patients all over the globe for being painless and side effect-less; the treatment time is also short.

Acoustic wave treatment helps one build the ideal body. However it has to be coupled with diet control, exercise, and fluid intake. The treatment should be given 6 to 12 times (once or twice a week). The following treatment should be given at least two days after the previous one.

Moreover, Decell's acoustic wave treatment boasts the excellent pain relieving ability. Patients with chronic muscle pain could expect to experience the pain relieving effect after 6 to 10 treatments.

The products of Daeyang Medical, who manufactures diverse medical equipment, have acquired quality certifications such as KGMP, CE MDD, FDA, and CMDCAS and are exported to 70 different countries. Globally recognized company Daeyang Medical is expected to continue the company‘s reputation with its new product Decell’s efficacy.

Daeyang Medical Co., Ltd.: http://www.daeyangmed.com/en/main.html